On Global Accessibility Awareness Day, here are product and feature updates built by and for people with disabilities
May 18 is Global Accessibility Awareness Day (GAAD), which is a moment for everyone to talk, think, and learn about digital access and inclusion. With over one billion people with disabilities in the world, this work extends beyond a single day - especially for teams at Google that work to make the world a more accessible place. Here's a look at new and recently launched features that are made with and for people with disabilities.
Cerevel and Pfizer are using the Target and Lead Identification Suite-and Colossal Biosciences is adopting the Multiomics Suite-to bring therapeutics to market faster
Google Cloud announced two new AI-powered life sciences solutions to accelerate drug discovery and precision medicine for biotech companies, pharmaceutical firms, and public sector organizations. Available worldwide today, the Target and Lead Identification Suite helps researchers better identify the function of amino acids and predict the structure of proteins; and the Multiomics Suite accelerates the discovery and interpretation of genomic data, helping companies design precision treatments.
As technology continues to advance, so do efforts by cybercriminals who look to exploit vulnerabilities in software and devices. This is why at Google and Android, security is a top priority, and we are constantly working to make our products more secure.
One way we do this is through our Vulnerability Reward Programs (VRP), which incentivize security researchers to find and report vulnerabilities in our operating system and devices.
We are pleased to announce that we are implementing a new quality rating system for security vulnerability reports to encourage more security research in higher impact areas of our products and ensure the security of our users. This system will rate vulnerability reports as High, Medium, or Low quality based on the level of detail provided in the report.
See all Archived Google News articles
See all articles from this issue
|
